《心脏与 COVID-19：心脏病学家须知》。

Universidade de São Paulo - Instituto do Câncer do Estado de São Paulo, São Paulo, SP - Brasil.

Universidade de São Paulo Instituto do Coração, São Paulo, SP - Brasil.

Arq Bras Cardiol. 2020 May 11;114(5):805-816. doi: 10.36660/abc.20200279.

In face of the pandemic of the novel coronavirus disease 2019 (COVID-19), the management of patients with cardiovascular risk factors and/or disease is challenging. The cardiovascular complications evidenced in patients with COVID-19 derive from several mechanisms, ranging from direct viral injury to complications secondary to the inflammatory and thrombotic responses to the infection. The proper care of patients with COVID-19 requires special attention to the cardiovascular system aimed at better outcomes.

面对 2019 年新型冠状病毒病（COVID-19）大流行，心血管危险因素和/或疾病患者的管理极具挑战性。COVID-19 患者的心血管并发症源自多种机制，从直接的病毒损伤到继发于感染的炎症和血栓形成反应的并发症不等。COVID-19 患者的适当护理需要特别注意心血管系统，以实现更好的结果。